Introduction B23 (also known as nucleophosmin, numatrin or NO38) is an abundant nucleolar protein involved in many cellular activities including ribosome biogenesis, maintenance of genomic integrity and import of proteins into the nucleus (Okuwaki, 2008) . The multiple functions of B23 make it both a potential oncogene and a potential tumor suppressor, depending on expression levels and environmental stimuli (Grisendi et al., 2006) . B23 possesses a nuclear-localization signal and a nuclearexport signal, which allows it to shuttle between nucleus and cytoplasm (Hingorani et al., 2000; Wang et al., 2005) . The shuttling property of B23 contributes to its activity in various cellular processes including the transport of pre-ribosomal particles, the response to stress stimuli such as UV irradiation and hypoxia, as well as cell cycle regulation (Yung et al., 1985; Wu et al., 2002; Brady et al., 2004) .
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a major group of pre-mRNA-binding proteins that participate in various steps of mRNA processing as well as the export, translation and stability of mRNAs (Krecic and Swanson, 1999; Dreyfuss et al., 2002) . The hnRNP protein family consists of 20 major hnRNPs, designated hnRNPA1 through U (Dreyfuss et al., 1993) . The hnRNP proteins have various functions at different stages of mRNA processing. For example, hnRNPA1 is a nucleocytoplasmic shuttling protein, which is important for mRNA export and splicing (Mayeda and Krainer, 1992; Izaurralde et al., 1997) . Protein hnRNPU, another hnRNPs family member, is able to stabilize specific mRNAs by binding to their 3 0 -untranslated regions (UTRs) (Yugami et al., 2007) . Moreover, hnRNPU has a regulatory function during the initial phases of transcription activation by affecting the activity of RNA Pol II (Kukalev et al., 2005) .
Here, we report that B23 is able to translocate into the cytosol in response to Pol I-, but not Pol II-induced transcription repression. B23 specifically interacts with hnRNPU and hnRNPA1 in the cytosol in an RNA dose-and type-dependent manner. The exact sequential order of the B23/hnRNPU/hnRNPA1 complex assembly is also defined. Disruption of this regulatory complex by depletion of individual protein component or by abolishing the interaction between B23 and hnRNPU through overexpression of 3 0 -UTR of bcl-xL mRNA, one of the hnRNPU-bound mRNAs, results in enhanced cell apoptosis because of actinomycin D (ActD)-or mitotic arrest-induced nucleolar segregation. These data show a novel function for B23 as a stress sensor in the assembly of B23/hnRNPU/hnRNPA1 complex to promote cell survival.
Results

B23 binds to hnRNPU and hnRNPA1 in the cytosol in response to ActD treatment
To investigate the functions of B23 during nucleolar segregation, we treated cells with ActD to mimic the physiological process of transcriptional arrest-induced nucleolar segregation. Treatment of HeLa cells with ActD (1 mg/ml) for 4 h was found to induce significant nucleolar segregation (Supplementary Information; Figure S1A ); therefore, this condition was used throughout this study.
First, we noticed that in response to ActD treatment, nucleolar B23 displayed a cytosolic translocation ( Figure 1a , bottom panel). In contrast, protein synthesis inhibitor CHX failed to trigger translocation of B23 (middle panel). In control experiments, the localization of GFP remained unchanged after these treatments.
Next, we sought to identify B23 interacting proteins, which could possibly be involved in B23-mediated response to ActD-induced nucleolar stress. Coimmunoprecipitation by anti-B23 antibody revealed two ActDresponsive and cytosolic-localized bands ( Figure 1b , lane 4), which were further analyzed by mass spectrometry and found to represent hnRNPU and hnRNPA1, respectively. As shown in Figure 1c , barely detectable hnRNPU, hnRNPA1 and low level of B23 were found in cytosol of unstressed cells, whereas a significant increase in the amount of all three proteins were detected in cytosol on ActD treatment (Figure 1c ; Supplementary Figure S1B ). The physical associations between B23 and hnRNPU or hnRNPA1 were only detected in the cytosolic, but not the nuclear fractions of ActD-treated cells (Figure 1d , lane 6 vs lane 8). As a control, no interaction was detected between B23 and hnRNPC1, indicating the specificity in the interactions between B23 and hnRNPU/A1. Moreover, by co-staining, we observed that co-localization of B23 and hnRNPU or hnRNPA1 occur in the same cells (Figure 1e ). To further confirm the cytoplasmic translocation of B23 in response to the Act D treatment, a GFP-tagged B23 was expressed in HeLa cells. The localizations of tagged B23 and hnRNPU in treated and untreated cells are shown in Supplementary Figure S1D . It is worthwhile to note that level of cytosolic translocated B23, hnRNPU or hnRNPA1 correlated positively with the extent of nucleolar segregation. As long as nucleoli remain intact, B23, hnRNPU or hnRNPA1 will stay in nuclei (see arrowheads in DIC column and antibody column; Supplementary Figure S1B), this observation indicates that the trigger signal for translocation and association of B23, hnRNPU and hnRNPA1 is likely to stem from nucleoli.
B23-hnRNPU interaction was induced by inhibition of RNA Pol I transcription ActD is a chemical agent, which inhibits activities of RNA Polymerase I and II and induces DNA damage (Perry and Kelley, 1970) . To define whether B23-hnRNPU interaction was induced by ActD-caused transcription inhibition or by translational inhibition, both ActD and CHX (cycloheximide, a eukaryotic translational inhibitor) were used. Coimmunoprecipitation experiments revealed that hnRNPU specifically interacts with B23 in the cytosolic extract from ActDbut not CHX-treated cells (Figure 2a , lane 11 vs lane 9; Supplementary Figure S1C , lane 8 vs lane 10), indicating that B23-hnRNPU interaction was likely because of transcriptional, but not translational, inhibition. Furthermore, a-amanitin, an RNA pol II-specific inhibitor, failed to affect the subcellular localization of B23 and hnRNPU ( Figure 2b , lanes 5, 6 vs lanes 1, 2), thus the B23-hnRNPU interaction in the cytosol was unlikely to occur by RNA Pol II inhibition (Figure 2c , lane 8 vs lane 9). Intriguingly, however, a-amanitin treatment resulted in a significant increase in the B23-hnRNPU interaction in the nucleus (Figure 2c , lane 12), (see below). Cells were also treated with DNA-damaging agents, including camptothecin and doxorubicin. The observation that neither agent noticeably promoted B23-hnRNPU interaction, despite the fact that residual interaction was detected, might be due to slight RNA degradation (see next result) during protein extraction process ( Figure 2d , lanes 6, 7 vs lane 8). Collectively, these data indicate that the B23-hnRNPU interaction in the cytosol was likely to be caused specifically by ActDinduced RNA pol I inhibition.
hnRNPU-B23 interaction is mediated by histone-binding domain of B23 and RNA-binding domain of hnRNPU Both B23 and hnRNPU were known to contain functional domains, which account for their distinctive biochemical functions (Hingorani et al., 2000; Kukalev Figure 1 B23 interacts with hnRNPA1 and hnRNPU in the cytosol on ActD treatment. (a) HeLa cells stably expressing GFP were treated with the 0.1% DMSO vehicle, CHX (25 mg/ml) and ActD (1 mg/ml), respectively, followed by immunostaining with anti-B23 antibody (red). The nuclei were counterstained with Hoechst 33342 (blue). (b) HeLa cells were either untreated (lanes 3 and 5) or treated with ActD (1 mg/ml) for 4 h. Nuclear and cytosolic fractions were then prepared and subjected to immunoprecipitation with anti-B23 antibody. Protein samples were separated by SDS-PAGE and visualized by Coomassie Blue staining. Bands specifically co-purified with B23 in the cytoplasmic fraction were excised and analyzed by mass spectrometry. The arrowheads indicate the position of the IgG heavy and light chains and the co-purified proteins. (c) HeLa cells were treated with or without ActD (1 mg/ml), and then fractionated into cytosolic (C) and nuclear (N) fractions. The subcellular distribution of indicated proteins was analyzed by western blotting. PARP and GADPH served as nuclear and cytosolic markers, respectively. (d) HeLa cells were treated with or without ActD, and the cytosolic and nuclear fractions were separately immunoprecipitated with anti-B23 antibody (lanes 5-8). The samples were analyzed by immunoblotting using the indicated antibodies. (e) HeLa cells were either mock treated or treated with ActD, followed by immunostaining using monoclonal antibody against B23, hnRNPA1 or hnRNPU. The nucleus was visualized by Hoechst staining. Representative images of cells are shown. The morphology of nucleoli was observed directly under a phase-contrast microscope (bright field). A full colour version of this figure is available at the Oncogene journal online. , 2005) . To identify the region of hnRNPU that required for the association with B23, a series of hnRNPU deletion mutants were constructed (Supplementary Figure S2A ) and tested for their interaction with B23 by Co-IP assays. As shown in Supplementary Figure S2B , the hnRNPUDRBD deletion form was unable to bind B23 (lane 8), and hnRNPUDDBD exhibited reduced interaction with B23 compared with wt-hnRNPU (lane 10 vs lane 11), indicating that the RBD and DBD of hnRNPU may be required for binding to B23. To clarify exactly which domain (DBD or RBD) of hnRNPU is the direct binding region for B23, we performed a GST-pull down assay. As shown in Supplementary Figure S2C , the RBD domain, but not the DBD domain of hnRNPU, is responsible for the binding to B23 (lane 6 vs lane 7). These data indicate that RBD domain of hnRNPU is both necessary and sufficient for binding to B23. Owing to the difficulties in expressing the full-length recombinant hnRNPU protein in vitro, we used hnRNPU-RBD to represent the fulllength hnRNPU in all the following in vitro binding assays.
We again mapped the region of B23 that interacts with hnRNPU. As seen in Supplementary Figure S2D , lane 4, B23 histone-binding domain (HBD) was crucial for its interaction with hnRNPU. It is interesting to note The immunoprecipitates were analyzed with anti-hnRNPU and anti-B23 antibodies. (b) HeLa cells were either untreated or treated with ActD (10 ng/ml) or a-amanitin (1 mg/ml), and then the cytosolic and nuclear fractions were prepared. The protein distribution of B23 and hnRNPU was detected by western blot. GAPDH was detected as a cytosolic marker. (c) HeLa cells were treated as described in (b), and the cytosolic and nuclear fractions were prepared and immunoprecipitated with anti-hnRNPU antibody. The immunoprecipitates were analyzed by immunoblotting. (d) HeLa cells were either untreated or treated with various drugs including camptothecin (CPT, 4 mg/ml), doxorubicin (1 mM) and ActD (1 mg/ml). After treatment, whole-cell extracts were immunoprecipitated with anti-B23 antibody. The interaction between B23 and hnRNPU on these treatments were examined by immunoblotting with anti-B23 and anti-hnRNPU antibody.
B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al that although hnRNPU-RBD domain is enriched in positively charged amino acids, deletion of a cluster of negatively charged amino-acid residues in B23 HBD (DDE repeat) does not seem to affect its interaction with His-hnRNPU-RBD (Supplementary Figure S2D , lane 6), indicating that the B23-hnRNPU interaction is not simply based on electrostatic force.
B23-hnRNPU interaction is regulated by the hnRNPU-bound mRNAs Next, we sought to define the mechanism regulating the B23-hnRNPU interaction. As hnRNPU interacted with B23 through its RNA-binding domain, we then assumed that in untreated cells, hnRNPU normally interacted with RNA molecules, which might impede its association with B23. To test this hypothesis, we compared the effect of RNase A and DNase I on B23-hnRNPU interaction. As shown in Figure 3A , the interaction between B23 and hnRNPU in the cytosol was significantly enhanced by RNase A treatment (lane 9 vs lane 7). Moreover, the B23-hnRNPU association, which does not occur in unstressed nucleus (lane 4), takes place in RNase A-treated nucleus, whether cells were pretreated with ActD or not (lanes 6 and 12). In contrast, such effects were not observed when DNase I was applied (lanes 2, 5, 8 and 11), indicating that it was RNA, but not DNA, that hindered the binding of hnRNPU to B23. This also explains why B23-hnRNPU interaction could be detected in a-amanitin-treated nucleus, as nascent mRNA transcripts were greatly diminished under that treatment.
To characterize what kind of RNA participates in the regulation of B23-hnRNPU interaction, a series of in vitro binding assays were performed using bacterially purified GST-B23 and His-tagged hnRNPU-RBD. To exclude the possibility that RNA contamination from Escherichia coli host cells may interfere the binding of GST-B23 to His-hnRNPU-RBD, RNase A was included in this assay, and as seen in Figure 3Ba , the B23-hnRNPU interaction was unaffected by RNase A treatment (lane 5 vs lane 4), showing that this in vitro binding system is suitable for our purpose. As shown in Figure 3Bb , when incubated with purified B23 and hnRNPU-RBD, mRNA exerted the most profound effect on B23-hnRNPU interaction compared with total RNA and ribosomal RNA (middle panel, lane 5 vs lanes 3, 4). In contrast, genome DNA showed little, if any, effect on B23-hnRNPU interaction (lane 6 vs lane 2).
As both B23 and hnRNPU could bind to RNA, we next designed an assay system to examine which protein, B23 or hnRNPU, once bound to RNA, would affect its further interaction with the other. As illustrated in Supplementary Figure S3A , beads-bound GST-B23 was first incubated with total RNA isolated from unstressed cells, and then washed thoroughly before incubating with purified His-hnRNPU-RBD; or alternatively, beads-bound GST-B23 incubated with His-hnRNPU-RBD, which was already pre-incubated with total RNA from unstressed cells. As shown in Figure 3Ca , pre-incubation of hnRNPU with RNA significantly inhibited its binding to B23 (lower panel, lane 2 vs lane 1, the asterisk indicates the treatment that B23 was preincubated with RNA), indicating that B23/hnRNPU interaction is regulated by hnRNPU-bound RNA, but not B23-bound RNA. More strikingly, this inhibition was in a dose-dependent manner (Figures 3Cb and c) .
As shown above, the interaction between B23 and hnRNPU was affected by cellular RNA (especially mRNA), and ActD was shown to trigger B23-hnRNPU interaction in the cytosol, it is, therefore, expected that the compositional change in cytosolic RNA in response to ActD may account for the B23-hnRNPU interaction in the cytosol. This hypothesis was supported by the data shown in Figure 3D ; cytosolic mRNA from nonstressed cells inhibited the binding of B23 to hnRNPU more effectively than that from ActD-treated cells (lane 5 vs lane 6). Notably, the inhibition of B23-hnRNPU interaction was partially recovered by cytosolic mRNA from B23 knocking down cells (lane 8 vs lane 6, and lane 7 vs lane 5). This is an interesting observation because it implies that in response to ActD, knocking down of B23 might decrease some uncharacterized cellular RNAs, which normally impedes the B23-hnRNPU interaction, resulting in an increase in binding of B23 to hnRNPU.
B23/hnRNPU/hnRNPA1 complex is assembled in a sequential manner As hnRNPA1 was also identified as a binding partner of B23 in the cytosol of ActD-treated cells (Figure 1b) , we, therefore, examined the relationship among B23, hnRNPU and hnRNPA1. We first tested the interaction between B23 and hnRNPA1 by in vitro pull down assay. Unexpectedly, although the interaction between wt-B23 and hnRNPA1 was weak, three B23 deletion mutants, especially the HBD deletion mutant, showed strong interactions with hnRNPA1 ( Figure 4a , upper panel, lanes 4, 5, 6 vs lane 3). As the HBD of B23 was required for its binding to hnRNPU, we then tested whether binding of B23 to hnRNPU, by which B23 HBD domain has been masked, could increase the interaction between B23 and hnRNPA1. As shown in Figure 4b , enclosure of hnRNPU-RBD, which covers the HBD domain of B23, was found to greatly enhance the binding of B23 to hnRNPA1 (upper panel, lane 4 vs lane 3), despite that His-tagged hnRNPU-RBD by itself was unable to be precipitated with hnRNPA1 (Supplementary Figure S3B , lane 5). Addition of total RNA extracted from non-stressed cells greatly weakened the binding of hnRNPU to B23 (Figure 4b , lane 5 vs lane 2), and as a result, the association between B23 and hnRNPA1 was much reduced (upper panel, lane 7 vs lane 4).
We next tested whether a complex of B23-hnRNPU was required for B23 to interact with hnRNPA1 in vivo. As shown in Figure 4c , hnRNPU was efficiently co-immunoprecipitated with B23 and hnRNPA1 in the cytosol of ActD-treated cells (lane 10). However, in B23-knockdown cells, coimmunoprecipitation of hnRNPU with hnRNPA1 did not occur either in the presence or absence of ActD treatment (upper panel, lane 11, 12 vs B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al lanes 9, 10). The smears, which possibly were resulted from non-specificity of antibodies used or the boiling procedure of the beads, displayed in lanes 9, 11 and 12 of bottom panel are not B23 bands. This data indicates that it is the B23-hnRNPU complex, but not B23 alone, that interacts with hnRNPA1. In addition, the formation of the B23/hnRNPA1/hnRNPU complex induced by ActD was further confirmed by a sequential IP with ectopically expressing FLAG-B23 and HA-hnRNPA1.
As shown in Supplementary Figure S3C , the tri-complex isolated by the sequential IP procedure was presented in the ActD-treated cells (lane 12). On the basis of these observations, we proposed a model explaining the possible sequence of assembly for B23/hnRNPU/ hnRNPA1 complex (Figure 4d) . In unstressed cells, hnRNPU and hnRNPA1 are both bound to mRNA in nucleus and none of them physically interacts with B23. ActD treatment led to the translocation of B23, B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al hnRNPU and hnRNPA1 from nucleus to cytoplasm and a decrease in some specific hnRNPU-bound mRNAs (for example BcL-xL mRNA, see below), resulting in an increased association between B23 and hnRNPU, thus allowing hnRNPA1 to bind to B23.
Identification of Bcl-xL mRNA as a regulator for the interactions between B23 and hnRNPU We showed that mRNA affects B23-hnRNPU interaction; therefore, we sought to identify specific mRNA molecules that are involved in regulating B23-hnRNPU interaction. We first investigated several reported candidate mRNAs, including BcL-xL, TNF-a,GADD45a, HOXA2, IER3 and p53 (Iervolino et al., 2002; Takagi et al., 2005; Yugami et al., 2007) . Among them, only Bcl-xL and TNF-a cytosolic mRNA were found to be decreased on ActD treatment (data not shown). These two mRNAs were tested for their binding to hnRNPU through an in vivo IP-RT-PCR assay. Successful Co-IP under the conditions indicated in Figure 5Aa was shown by western blotting (lanes 9-12). Moreover, ActD treatment led to a reduction in the amount of both hnRNPU-associated cytosolic Bcl-xL and TNF-a mRNA (Figure 5Ab , lane 10 vs lane 9), which raises the possibility that these mRNAs could be regulators of the B23-hnRNPU interaction. To test this idea, the 3 0 -UTR regions (to which hnRNPU binds) of Bcl-xL and TNF-a were transcribed in vitro (Figure 5Bb ) and then incubated with purified B23 and hnRNPU. As shown in Figure 5Ba , addition of Bcl-xL 3 0 -UTR almost completely blocked the binding of hnRNPU-RBD to B23 (upper panel, lane 4 vs lane 3), whereas TNF-a 3 0 -UTR displayed only marginal inhibitory effect (lane 5 vs lane 3), implying that TNF-a mRNA is unlikely to be involved in modulating the interaction between B23 and hnRNPU. To further verify the function of bcl-xL mRNA in the formation of hnRNPU/hnRNPA1/B23 tri-complex, we performed an in vivo assay. As shown in Figure 5C , ectopically expressing Bcl-xL 3 0 -UTR resulted in dramatic loss of endogenous hnRNPU and hnRNPA1 in the anti-B23 immunoprecipitates (lane 6 vs lane 5). Overall, these data suggest that Bcl-xL mRNA has an important function in regulating the interaction between hnRNPU and B23, and further affects the formation of the tri-complex hnRNPU/ hnRNPA1/B23. B23 affects the cytosolic/nuclear ratio of hnRNPU and hnRNPA1 on ActD stimulation As shown above, B23 translocated from nucleolus to the cytosol on ActD treatment, an event that is correlated with cytosolic accumulation of hnRNPA1 and hnRNPU (Figure 1e ). To examine whether the relocalization of B23 influences the nucleocytoplasmic trafficking of hnRNPA1 and hnRNPU on ActD treatment, the cytosolic/nuclear ratios of these proteins were compared in wild-type cells and cells stably expressing shRNA against B23. The effectiveness of RNAi was confirmed by immunoblot analysis ( Figure 6B ). As shown in Figure 6A , knockdown of B23 enhanced the cytosolic/nuclear ratio of hnRNPU and hnRNPA1 on ActD treatment (lanes 5, 6 vs lanes 3, 4), indicating B23 may be involved in facilitating the relocation of hnRNPU and hnRNPA1 from cytosol to nucleus after ActD treatment. Coomassie blue staining of cytosolic and nuclear extracts were shown to ensure the ratios of cytosolic and nuclear proteins examined were comparable. This western blot data was further substantiated by immunostaining analyses (Supplementary Figure S4A vs S1B).
B23-hnRNPU-hnRNPA1 complex contributes to the inhibition of ActD-induced apoptosis
To understand the functional significance of the cytosolic accumulation of B23, hnRNPA1 and hnRNPU and the resultant complex formation in response to ActD, we compared the ActD-induced apoptosis for wild-type and B23-knockdown cells. As shown in Figure 6B , ActD was more effective in inducing apoptosis in the absence of B23 than in its presence. Similar results were obtained in cells devoid of hnRNPA1 or hnRNPU ( Figure 6B ; Supplementary Figure S4C ); these observations suggest that missing any one of the protein components of B23-hnRNPU- Figure 3 The interaction between hnRNPU and B23 is regulated by mRNAs. (A) HeLa cells were treated with or without ActD, fractionated and immunoprecipitated with anti-B23 antibody. RNase A (200 mg/ml) or DNase I (40 mg/ml) was included throughout the fractionation and immunoprecipitaiton process in the indicated samples. Samples were analyzed by immunoblotting with anti-B23 and anti-hnRNPU antibody. (B): (a) E. coli expressed and purified His-tagged hnRNPU-RBD was incubated with bead-bound GST-B23 or GST alone. RNase A was added during the incubation in the indicated sample (lane 5). After incubation, beads were washed and boiled, followed by SDS-PAGE analysis. The purity of the proteins was visualized by Ponceau S staining. Equal amounts of beadbound GST-B23 were shown by immunoblotting with anti-GST antibody. The co-purified His-hnRNPU protein was detected by immunoblotting with anti-His antibody. (D) Cytoplasmic mRNAs were extracted from wild-type or B23-knockdown HEK293 cells treated with or without ActD. Equal amount of mRNA samples were incubated with purified GST-B23 and His-hnRNPU-RBD in a GST-pull down assay. The amount of His-hnRNPU-RBD protein co-purified with GST-B23 was examined by SDS-PAGE and Coomassie Blue staining. The amount of GST-B23 protein used in this assay was shown to be equal.
B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al Figure 4 Binding of hnRNPU to B23 enhances the association between B23 and hnRNPA1. (a) E. coli expressed and purified GST-fused wild-type and mutant B23 proteins were incubated with recombinant His-hnRNPA1 protein in a GST-pull down assay. The associated His-hnRNPA1 protein was detected by immunoblotting using anti-His antibody (upper panel). The amount and purity of the purified proteins used in this assay was shown by Coomassie blue staining (bottom panel). (b) Bead-bound GST-B23 fusion protein was incubated with purified recombinant hnRNPU-RBD and hnRNPA1, and total RNA extracted from HEK293 cells in various combinations as indicated. After incubation, the beads were washed extensively, boiled and separated by SDS-PAGE. Proteins co-purified with GST-B23 were analyzed by immunoblotting with anti-His antibody. A Coomassie-stained gel is shown to indicate that equal amount of the GST-B23 fusion protein was used in the experiment (lower panel). (c) Cytoplasmic extracts were prepared from wild-type or B23-knockdown HEK293 cells treated with or without ActD, immunoprecipitated with the indicated antibodies, followed by western blot analysis (lanes 5-12). The expression levels of endogenous B23, hnRNPU and hnRNPA1 in the cytoplasmic fraction was also examined (lanes 1-4). (d) A proposed model depicting the predicted sequential association for B23, hnRNPU and hnRNPA1 on ActD-induced stress.
B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al hnRNPA1 complex will cause more apoptosis. We also used time-lapse video microscopy to follow the fate of individual cells, and more apoptosis were observed in B23-knockdown cells after ActD treatment (Supplementary Figure S4B ). As shown, 3 0 -UTR of Bcl-xL mRNA hampers the interaction between B23 and hnRNPU, and subsequently dissociates the B23-hnRNPU-hnRNPA1 assembly, yet it does not affect their individual protein component level (Figure 6Cb, lane 3 vs lane 1) . We, therefore, used 3 0 -UTR of Bcl-xL as a tool to manipulate the association/dissociation of B23-hnRNPU-hnRNPA1 complex without affecting each component's level. As shown in Figure 6Ca , overexpression of Bcl-xL 3 0 -UTR significantly enhanced ActD-induced apoptosis in wild-type cells (column 2 vs 6). In contrast, Bcl-xL 3 0 -UTR overexpression did not display obvious effect on cell viability in B23-knockdown cells (column 4 vs 8) after ActD treatment; this could be explained that once tri-complex is dissociated, for example by knockdown of B23, further addition of bcl-xL 3 0 -UTR is futile to affect the extent of apoptosis. Together, these data suggest that a functional complex comprised of B23, hnRNPU and hnRNPA1 was responsible for protecting cells from ActD-induced apoptosis. In addition, we also found that exogenous Bcl-xL 3 0 -UTR showed little effect on endogenous Bcl-xL protein level (Figure 6Cb , lane 4 vs lane 2), thus Figure 5 Bcl-xL mRNA is a regulator of the interaction among B23-hnRNPU-hnRNPA1. (A) Wild-type and B23-knockdown HEK293 cells treated with ActD or not were subjected to subcellular fractionation. Cytosolic fractions were immunoprecipitate with anti-hnRNPU antibody. After incubation, the beads were washed, and the immunocomplexes were eluted. (a). 10% of the eluted immunocomplexes were subjected to western blot analysis to detect the proteins in the immunoprecipitates (lanes 9-12). The expression level of proteins in the cytosolic (lanes 1-4) and nuclear (lanes 5-8) fractions was also examined. (b) The mRNA levels of the indicated genes in the cytosolic and nuclear fractions were analyzed by RT-PCR. hnRNPU-bound RNA was extracted from the remaining eluted immunocomplexes (90%) and amplified by RT-PCR (lanes 9-12). Ku70 was used as a negative control here. Each RT-PCR band was determined by densitometry, and the relative density of the PCR product from non-treated B23-wild-type cells in each group was assigned an arbitrary value of 1. (B) (a) An in vitro binding assay was performed with purified GST-B23, His-hnRNPU-RBD and in vitro transcribed 3 0 -UTR of Bcl-xL or TNF-a in various combinations as indicated. The amount of hnRNPU-RBD that associated with GST-B23 was examined by western blot using anti-His antibody. The purity of the proteins was assessed by Coomassie blue staining. (b) The purity of the in vitro transcription products used in the binding assay was visualized by ethidium bromide. (C) HEK293 cells were transfected with either a plasmid expressing the 3 0 -UTR region of Bcl-xL or the empty vector. Transfectants were then treated with or without ActD. Whole-cell lysates were subjected to immunoprecipitation with anti-B23 antibody, followed by immunoblotting analysis.
B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al to exclude the possibility that apoptosis was caused by inhibition of endogenous Bcl-xL. We further showed that B23/hnRNPU/hnRNPA-mediated pro-survival effect represents a caspase-independent event, as treatment with the pan-caspase inhibitor z-VAD-fmk failed to reduce the enhanced ActD-induced apoptosis B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al observed in B23-knockdown cells or cells expressing Bcl-xL 3 0 -UTR ( Figure 6D , columns 6, 9 vs 5, 8). Moreover, disassociation of B23/hnRNPU/hnRNPA tri-complex by knockdown of either one of the three components failed to cause release of mitochondrial apoptotic factors including cytochrome c, Smac/ DIABLO or HtrA/Omi (data not shown), indicating that B23/hnRNPU/hnRNPA-protected apoptosis induced by ActD is unlikely to undergo mitochondrialmediated pathway.
Interfering with the association of B23/hnRNPU/ hnRNPA1 promotes apoptosis caused by mitotic arrest As shown above, ActD-induced nucleolar segregation leads to the formation of B23/hnRNPU/hnRNPA1 complex. Similarly, when cells enter mitosis, they will also undergo the process of nucleolar segregation. To examine whether this tri-complex can be formed during M phase entry, we performed a Co-IP assay using cells arrested at either G1/S or G2/M. As shown in Figure 7a , interaction between B23 and hnRNPU was observed in cells arrested at pro-metaphase (Figure 7a , lane 7), but not G1 phase in which the nucleoli were completely assembled (Figure 7a , lane 6). We further investigated whether B23/hnRNPU/hnRNPA1 complex exerts an effect on the cell cycle progression. Wild-type or B23-knockdown HEK293 cells were transfected with or without a plasmid expressing the 3 0 -UTR of Bcl-xL before being arrested at pro-metaphase by nocodazole treatment, and followed by recovery in fresh medium for up to 8 h. Analysis of cells released from pro-metaphase block by FACS (Supplementary Figure S5) revealed that disruption of association of B23/hnRNPU/ hnRNPA1 in wild-type cells by ectopically expressed 3 0 -UTR of Bcl-xL promotes apoptosis induced by mitotic arrest (Figure 7b , pink vs blue). Moreover, ectopic expression of Bcl-xL 3 0 -UTR in B23-knockdown cells exhibited more prominent apoptosis than in wild-type B23 cells (Figure 7b , green vs pink), which probably is due to further reduced interaction among B23, hnRNPU and hnRNPA1.
B23-knockdown cells were more susceptible to apoptosis than their B23 wild-type counterparts after cell cycle release from G1 arrest (Figure 7c , red vs blue). This B23-mediated apoptosis induced by G1 arrest, however, is probably independent of B23/hnRNPU/ hnRNPA1 complex; this is because when cells were at G1/S phase, nucleoli had been completely assembled and B23/hnRNPU/hnRNPA1 complex was not present.
In contrast to what had been found in induction of mitotic arrest, overexpression of the 3 0 -UTR of the Bcl-XL mRNA showed no effect on G1/S arrestinduced apoptosis (Figure 7c , pink vs blue, green vs red; Supplementary Figure S5B ), this can be explained that when cells are at G1/S phase, 3 0 -UTR of the Bcl-XL is expected to show a null effect on the tri-complex because of the absence of B23/hnRNPU/hnRNPA1 formation.
Discussion
The above experimental evidence supports the existence of a novel signaling pathway that protects cells from nucleolar stress. In non-stressed cells, B23 is localized in nucleolus, whereas hnRNPU and hnRNPA1 are mainly localized in nucleoplasm; thus, B23 are unlikely to interact with hnRNPU and hnRNPA1. However, when nucleoli undergo segregation as a result of ActDinduced transcription inhibition, B23 translocates into the cytosol and concurrently, hnRNPU and hnRNPA1 are also found to accumulate in the cytosol. On ActD treatment, level of the mRNAs that impede the binding of B23 to hnRNPU, as exemplified by the cytosolic Bcl-xL mRNA, is also decreased, allowing association to occur among B23, hnRNPU and hnRNPA1. These proteins are found to form a tri-complex in a sequential manner and their association favors cells survival.
Our current data has clearly showed a pro-survival function of the B23-hnRNPU-hnRNPA1 complex against nucleolar stress-induced apoptosis. Intriguingly, this complex seems to function in a caspase-independent manner. Although the exact mechanism remains to be explored, one possibility is that B23, hnRNPU and hnRNPA1 may influence the RNA processing machinery and trigger cells to undertake a yet uncharacterized B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al nuclear apoptotic signaling other than caspase-involved apoptotic pathway in response to nucleolar stress. An interesting work reported recently by Guil and Caceres showed that hnRNPA1 could specifically bind to human pri-miR-18a, a component of the polycistronic miR-17-92 cluster, and facilitate its processing by Drosha, suggesting a potential link between hnRNPA1 and miRNA processing (Guil and Caceres, 2007) . Our preliminary data showed that the interaction between B23 and hnRNPA1 was able to affect hnRNA1-mediated processing of the miR-18a precursor (Supplementary Figure S6) , and whether the B23/hnRNPU/ hnRNPA1 complex-mediated cell survival is due to regulating miR-18a through B23-hnRNA1-hnRNU interaction is currently being investigated.
In addition, ActD has long been used as an antitumor drug (Frei, 1974) , and the pathways described here may be of clinical significance. This study, together with earlier reports from other group, indicates that B23 is a 'difficile molecule'. On one hand, B23 overexpression accounts for the drug resistance of tumor cells to ActD treatment, and on the other hand, lacking of B23 will induce tumorigenesis by impairing genome stability (Grisendi et al., 2005) . New therapeutic agents that specifically targeting the B23-invovled pathways, for example 3 0 -UTR of bcl-xL mRNA that block B23-hnRNPU interaction, may provide the opportunity to achieve more effective and rational cancer therapy.
Materials and methods
Cell culture and manipulations Cells were cultured in DMEM medium with 10% fetal bovine serum. Transient transfection was performed with Lipofectamine 2000 (Invitrogen) according to manufacturer's instructions. B23, hnRNPU and hnRNPA1 expression was knocked down by RNA interference. Double-stranded oligonucleotides specifically targeting the sequence of each gene (see Supplementary Information) was cloned into the pSuperRetroPuro vector (OligoEngine, Seattle, WA, USA). Cells were infected with the shRNA expressing retrovirus and selected with 2 mg/ ml puromycin. The stable shRNA-modulated cell clones were isolated and expanded for analysis.
Antibodies and reagents
The following antibodies were used in this study: monoclonal anti-B23 antibody (Sigma-Aldrich, St Louis, MO, USA), Figure 7 Effect of disruption of B23/hnRNPU/hnRNPA1 complex formation on apoptosis caused by mitotic arrest. (a) HeLa cells were either untreated or subjected to serum starvation or drug treatment as indicated. Cell lysates were then immunoprecipitated with hnRNPU antibody, followed by western blot analysis using antibodies against B23 and hnRNPU. The input corresponded to 10% of the lysates used for the immunoprecipitation (lanes 1-4) . (b, c). Wild-type or B23-knockdown HEK293 cells were either mock transfected or transfected with the plasmid expressing the 3 0 -UTR of Bcl-xL; 24 h after transfection, cells were either arrested at pro-metaphase by nocodazole treatment (b) or arrested at G1 phase by serum deprivation (c). Cells were then released into fresh medium and harvested at the indicated times. Cell cycle distribution and DNA content were measured by PI staining and FACS analysis. Graphic representation of the percentage of apoptotic cells were obtained from analysis of data points in Supplementary Figure S5A and S5B, respectively. B23 acts as a nucleolar stress sensor and promotes cell survival Z Yao et al
